![]()
|
|
||||||||
(Received for publication, December 11, 1996)
From We reported previously the cloning of a novel
human serine protease inhibitor containing two Kunitz-like domains,
designated as placental bikunin, and the subsequent purification of a
natural counterpart from human placental tissue (Marlor, C. W.,
Delaria, K. A., Davis, G., Muller, D. K., Greve, J. M., and
Tamburini, P. P. (1997) J. Biol. Chem. 272, 12202-12208). In this report, the 170 residue extracellular domain of
placental bikunin (placental bikunin(1-170)) was expressed
in baculovirus-infected Sf9 cells using its putative signal peptide.
The resulting 21.3-kDa protein accumulated in the medium with the
signal peptide removed and could be highly purified by sequential
kallikrein-Sepharose and C18 reverse-phase chromatography.
To provide insights as to the potential in vivo functions
of this protein, we performed an extensive investigation of the
inhibitory properties of recombinant placental
bikunin(1-170) and both of its synthetically prepared Kunitz domains. All three proteins inhibited a number of serine proteases involved in the intrinsic pathway of blood coagulation and
fibrinolysis. Placental bikunin(1-170) formed
inhibitor-protease complexes with a 1:2 stoichiometry and strongly
inhibited human plasmin (Ki = 0.1 nM),
human tissue kallikrein (Ki = 0.1 nM),
human plasma kallikrein (Ki = 0.3 nM)
and human factor XIa (Ki = 6 nM).
Conversely, this protein was a weaker inhibitor of factor VIIa-tissue
factor (Ki = 1.6 µM), factor IXa
(Ki = 206 nM), factor Xa
(Ki = 364 nM), and factor XIIa
(Ki = 430 nM). This specificity profile
was to a large extent mimicked, albeit with reduced potency, by the
individual Kunitz domains. As predicted from this in vitro specificity profile, recombinant placental bikunin(1-170) prolonged the clotting time in an activated partial thromboplastin time
assay.
Volume 272, Number 18,
Issue of May 2, 1997
pp. 12209-12214
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
,
,
and
Preclinical Research,
Institute for Research Technologies,![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Szabo, J. P. Hobson, K. List, A. Molinolo, C.-Y. Lin, and T. H. Bugge Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity J. Biol. Chem., October 24, 2008; 283(43): 29495 - 29504. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakamura, F. Abarzua, A. Hongo, J. Kodama, Y. Nasu, H. Kumon, and Y. Hiramatsu Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer Ann. Onc., August 9, 2008; (2008) mdn556v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Moran, W. Li, B. Fan, R. Vij, C. Eigenbrot, and D. Kirchhofer Pro-urokinase-type Plasminogen Activator Is a Substrate for Hepsin J. Biol. Chem., October 13, 2006; 281(41): 30439 - 30446. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Odet, A. Verot, and B. Le Magueresse-Battistoni The Mouse Testis Is the Source of Various Serine Proteases and Serine Proteinase Inhibitors (SERPINs): Serine Proteases and SERPINs Identified in Leydig Cells Are under Gonadotropin Regulation Endocrinology, September 1, 2006; 147(9): 4374 - 4383. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Morris, D. Gentle, M. Abdulrahman, E. N. Maina, K. Gupta, R. E. Banks, M. S. Wiesener, T. Kishida, M. Yao, B. Teh, et al. Tumor Suppressor Activity and Epigenetic Inactivation of Hepatocyte Growth Factor Activator Inhibitor Type 2/SPINT2 in Papillary and Clear Cell Renal Cell Carcinoma Cancer Res., June 1, 2005; 65(11): 4598 - 4606. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Caldwell, R. C. Boucher, and M. J. Stutts Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L813 - L819. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tian, E. Huitema, L. da Cunha, T. Torto-Alalibo, and S. Kamoun A Kazal-like Extracellular Serine Protease Inhibitor from Phytophthora infestans Targets the Tomato Pathogenesis-related Protease P69B J. Biol. Chem., June 18, 2004; 279(25): 26370 - 26377. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Borgono, I. P. Michael, and E. P. Diamandis Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer Mol. Cancer Res., May 1, 2004; 2(5): 257 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukai, O. Yokosuka, T. Chiba, Y. Hirasawa, M. Tada, F. Imazeki, H. Kataoka, and H. Saisho Hepatocyte Growth Factor Activator Inhibitor 2/Placental Bikunin (HAI-2/PB) Gene Is Frequently Hypermethylated in Human Hepatocellular Carcinoma Cancer Res., December 15, 2003; 63(24): 8674 - 8679. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kirchhofer, M. Peek, W. Li, J. Stamos, C. Eigenbrot, S. Kadkhodayan, J. M. Elliott, R. T. Corpuz, R. A. Lazarus, and P. Moran Tissue Expression, Protease Specificity, and Kunitz Domain Functions of Hepatocyte Growth Factor Activator Inhibitor-1B (HAI-1B), a New Splice Variant of HAI-1 J. Biol. Chem., September 19, 2003; 278(38): 36341 - 36349. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bridges, B. B. Newton, J. M. Pilewski, D. C. Devor, C. T. Poll, and R. L. Hall Na+ transport in normal and CF human bronchial epithelial cells is inhibited by BAY 39-9437 Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L16 - L23. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Itoh, H. Kataoka, M. Tomita, R. Hamasuna, Y. Nawa, N. Kitamura, and M. Koono Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa Am J Physiol Gastrointest Liver Physiol, April 1, 2000; 278(4): G635 - G643. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Thomas, S. Yung, and M. Davies Bikunin Present in Human Peritoneal Fluid Is in Part Derived from the Interaction of Serum with Peritoneal Mesothelial Cells Am. J. Pathol., October 1, 1998; 153(4): 1267 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Milstone, L. M. Harrison, R. D. Bungiro, P. Kuzmic, and M. Cappello A Broad Spectrum Kunitz Type Serine Protease Inhibitor Secreted by the Hookworm Ancylostoma ceylanicum J. Biol. Chem., September 15, 2000; 275(38): 29391 - 29399. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kataoka, T. Shimomura, T. Kawaguchi, R. Hamasuna, H. Itoh, N. Kitamura, K. Miyazawa, and M. Koono Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Specific Cell Surface Binding Protein of Hepatocyte Growth Factor Activator (HGFA) and Regulates HGFA Activity in the Pericellular Microenvironment J. Biol. Chem., December 15, 2000; 275(51): 40453 - 40462. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van Adelsberg, S. Sehgal, A. Kukes, C. Brady, J. Barasch, J. Yang, and Y. Huan Activation of Hepatocyte Growth Factor (HGF) by Endogenous HGF Activator Is Required for Metanephric Kidney Morphogenesis in Vitro J. Biol. Chem., April 27, 2001; 276(18): 15099 - 15106. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |